Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.

Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS. · 2006

Read Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. by Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1635730.txt.

Introduction

Ovarian tumors spread across the belly by sticking to its lining. Gubbels and co-authors pinned that sticking in 2006 to a tight molecular handshake. A mucin on tumor cells, MUC16, binds mesothelin, a protein on lining cells.

The binding was strong, with an affinity around 5 to 10 nanomolar, and reached its peak within five minutes. Sugars attached to MUC16 proved essential: stripping them killed the binding. Tumor cells bearing MUC16 clung far more to cells bearing mesothelin. Gubbels argues this grip, tuned to the belly's conditions, helps seed the spread of ovarian cancer.

Catalog record

CREATORGubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS.
YEAR2006
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1635730

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors By Jennifer AA Gubbels, Jennifer Belisle, Masanori Onda, Claudine Rancourt, Martine Migneault, Mitchell Ho, Tapan K Bera, Joseph Connor, Bangalore K Sathyanarayana, Byungkook Lee, Ira Pastan, Manish S Patankar Published in: Molecular Cancer DOI: 10.1186/1476-4598-5-50 ABSTRACT Background The mucin MUC16 and the glycosylphosphatidylinositol anchored glycoprotein mesothelin likely facilitate the peritoneal metastasis of ovarian tumors. The biochemical basis and the kinetics of the binding between these two glycoproteins are not clearly understood. Here we have addressed this deficit and provide further evidence supporting the role of the MUC16-mesothelin interaction in facilitating cell-cell binding under conditions that mimic the peritoneal environment. Results In this study we utilize recombinant-Fc tagged human mesothelin to measure the binding kinetics of this glycoprotein to MUC16 expressed on the ovarian tumor cell line OVCAR-3. OVCAR-3 derived sublines that did not express MUC16 showed no affinity for mesothelin. In a flow cytometry-based assay mesothelin binds with very high affinity to the MUC16 on the OVCAR-3 cells with an apparent Kd of 5–10 nM. Maximum interaction occurs within 5 mins of incubation of the recombinant mesothelin with the OVCAR-3 cells and significant binding is observed even after 10 sec. A five-fold molar excess of soluble MUC16 was unable to completely inhibit the binding of mesothelin to the OVCAR-3 cells. Oxidation of the MUC16 glycans, removal of its N-linked oligosaccharides, and treatment of the mucin with wheat germ agglutinin and erythroagglutinating phytohemagglutinin abrogates its binding to mesothelin. These observations suggest that at least a subset of the MUC16-asscociated N-glycans is required for binding to mesothelin. We also demonstrate that MUC16 positive ovarian tumor cells exhibit increased adherence to A431 cells transfected with mesothelin (A431-Meso+). Only minimal adhesion is observed between MUC16 knockdown cells and A431-Meso+ cells. The binding between the MUC16 expressing ovarian tumor cells and the A431-Meso+ cells occurs even in the presence of ascites from patients with ovarian cancer. Conclusion The strong binding kinetics of the mesothelin-MUC16 interaction and the cell adhesion between ovarian tumor cells and A431-Meso+ even in the presence of peritoneal fluid strongly support the importance of these two glycoproteins in the peritoneal metastasis of ovarian tumors. The demonstration that N-linked glycans are essential for mediating mesothlein-MUC16 binding may lead to novel therapeutic targets to control the spread of ovarian carcinoma. BACKGROUND The mucin MUC16 carries the peptide epitope CA125, which is a prominent molecular marker for monitoring the progression and recurrence of epithelial ovarian cancer (EOC) [1-3]. MUC16 is a very large mucin with an average molecular weight between 2.5–5 million Da [2,4]. The peptide backbone of MUC16 is composed of the N-terminal region, an extensive tandem repeat domain, and a C-terminal region with a short cytoplasmic tail [2]. The tandem repeat, a hallmark of all mucins, is composed of 18–60 repeats, each of which contains 156 amino acids [2]. The N-terminal domain has been proposed to be made up of 13,000 amino acids [4]. In addition to the extensive protein structure, MUC16 is also heavily glycosylated with both O-linked and N-linked oligosaccharides [5]. Enumeration of the basic structure of MUC16 has led to recent studies to define the biological properties of this mucin. The over expression of MUC16 by many tumors of epithelial origin suggest an important role for this mucin in tumorigenesis. We have demonstrated that MUC16 inhibits the cytolytic responses of human natural killer cells [6]. MUC16 also binds to galectin-1, a mammalian lectin that is expressed on human immune cells [7]. These studies suggest that one role of MUC16 is to prevent efficient anti-tumor immune responses. Another postulated function of MUC16 is to facilitate cell-cell interactions. A recombinant fragment of MUC16 composed of the cytoplasmic region and a partial tandem repeat domain binds to mesothelin, a glycoprotein that is highly expressed by ovarian tumors and mesotheliomas [8,9]. Mesothelin is normally expressed on the mesothelial cells lining the peritoneal cavity [8]. In a heterotypic cell adhesion assay, the epithelial ovarian tumor cells, OVCAR-3, bind to the mesothelin expressing murine endothelial-like cell line, LO [9]. Addition of increasing concentrations of an anti-mesothelin antibody inhibited the binding between these cells. These experiments suggest that mesothelin may play an important role in the metastasis of the ovarian tumors within the peritoneum. Mesothelin is a 40 kDa glycoprotein that is initially synthesized as a 70 kDa precursor [10]. Proteolytic cleavage results in the release of a 32 kDa fragment called the megakaryocyte potentiating factor [11]. The 40 kDa fragment of this precursor is anchored to the cell surface by a glycosylphosphatidyl inositol linkage and is referred to as mesothelin [8]. Initial experiments suggested a role for mesothelin in cell adhesion events [8]. However, since mesothelin knock-out mice do not exhibit any adverse pathology, the exact function of this molecule is not clear [12]. Considering the potential importance of the mesothelin-MUC16 interaction in ovarian tumor metastasis within the peritoneum, we have performed additional studies to carefully define its molecular characteristics. The data presented conclusively shows that mesothelin binds to native MUC16 expressed by the ovarian cancer cell line OVCAR-3 and also to MUC16 isolated from the peritoneal fluid of patients with EOC. Here we provide firm evidence that N-linked oligosaccharides of MUC16 are required for the binding of this mucin to mesothelin. Kinetic analysis is provided to demonstrate that mesothelin-MUC16 binding is a high affinity interaction that increases cell adhesion between MUC16 and mesothelin expressing cells. The importance of this observation to the peritoneal metastasis of ovarian tumors is discussed. RESULTS Mesothelin binds to native MUC16 Although mesothelin has been previously shown in direct assays to bind a recombinant fragment of MUC16 [9], it was important to conclusively demonstrate this interaction with native forms of this mucin. MUC16 was partially purified, by size exclusion chromatography, from OVCAR-3 cell culture media and from the peritoneal fluid of EOC patients as described in our earlier report [5]. These MUC16 samples showed strong binding to the recombinant mesothelin tagged with the Fc fragment of rabbit IgG (meso-Fc) in western blot overlay experiments (Figure 1a). The banding pattern observed after overlaying the membranes with meso-Fc was identical to that obtained in blots where the mucin was detected with the anti-MUC16 antibody, VK-8 (Figure 1b) [13,14]. We also determined that this observation was not an artifact of direct binding of the Fc portion to MUC16, as binding of purified rabbit Fc to the mucin could not be detected by western blotting (data not shown). [Figure: Mesothelin binds to native MUC16. (A) Meso-Fc binding to MUC16 samples from the ascites of patient #2 (100 U of CA125; lane 1) and from OVCAR-3 cells (500 U of CA125; lane 2) is shown (left panel). A control blot (right panel) with MUC16 from patient #2 (100 U of CA125; lane 1) and OVCAR-3 (500 U of CA125; lane 2) and meso-Fc (Lane 3) was overlaid with secondary antibody only. (B) For comparison, MUC16 from OVCAR-3 (100 U of CA125) was detected by VK-8 antibody. Note that since only 100 U (CA125) of OVCAR-3-derived MUC16 was loaded the banding pattern is identical to that of lane 1 of (A).] In our initial flow cytometry studies we observed that meso-Fc

Read the complete text